Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Remember: 31,615,369 shares held in treasury at average cost of

$ 0,452/share.

According to the last filing:

"During the period December 1, 2011 through January 9, 2012, we purchased 552,016 shares of our common stock"

I see three positive things with this:
1. 31+mio shares are a good war chest, IF the shareprice gets to $1,-
2. The average price paid for each share is $0,45 -I "guess" CF thinks we'll see this price range again - or why would he...
3. ...continue with the share buyback , especially with more than 550.000 shares in 40 days?

Either these shares are worth a "fortune" if we prevail at the Markman Hearing and with the followup or...well, not much...;-)

GLTA

Share
New Message
Please login to post a reply